In vivo synergistic effect of the immunomodulator AS101 and the PKC inducer bryostatin
- 1 August 1992
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 143 (1) , 143-153
- https://doi.org/10.1016/0008-8749(92)90012-e
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A new immunomodulating compound (AS-101) with potential therapeutic applicationNature, 1987
- Co-Induction of Lymphokine Synthesis by the Antineoplastic BryostatinsImmunobiology, 1987
- T‐Lymphocyte Activation: The Role of Protein Kinase C and the Bifurcating Inositol Phospholipid Signal Transduction PathwayImmunological Reviews, 1987
- Protein kinase C activation by diacylglycerol second messengersCell, 1986
- Transmembrane signalling by the T cell antigen receptor. Perturbation of the T3-antigen receptor complex generates inositol phosphates and releases calcium ions from intracellular stores.The Journal of Experimental Medicine, 1985
- The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level.The Journal of Immunology, 1984
- The role of protein kinase C in cell surface signal transduction and tumour promotionNature, 1984
- Reactions of hexanitroethane with alcoholsThe Journal of Organic Chemistry, 1983
- Characterization of cytosolic calcium-activated phospholipid-dependent protein kinase activity in embryonal carcinoma cells. Effect of retinoc acid-induced differentiation of F9 cells to parietal endoderm.Journal of Biological Chemistry, 1983
- The induction of clones of normal mast cells by a substance from conditioned mediumExperimental Cell Research, 1966